Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash & Equivalents (2016 - 2025)

Healthstream (HSTM) has disclosed Cash & Equivalents for 16 consecutive years, with $36.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 39.19% to $36.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.2 million, a 39.19% decrease, with the full-year FY2025 number at $36.2 million, down 39.19% from a year prior.
  • Cash & Equivalents was $36.2 million for Q4 2025 at Healthstream, down from $53.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $77.3 million in Q1 2025 to a low of $25.8 million in Q2 2023.
  • A 5-year average of $48.3 million and a median of $47.6 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 57.79% in 2021, then surged 78.77% in 2024.
  • Healthstream's Cash & Equivalents stood at $46.9 million in 2021, then decreased by 1.88% to $46.0 million in 2022, then fell by 12.36% to $40.3 million in 2023, then soared by 47.45% to $59.5 million in 2024, then tumbled by 39.19% to $36.2 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Cash & Equivalents are $36.2 million (Q4 2025), $53.5 million (Q3 2025), and $52.1 million (Q2 2025).